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Background: The infections caused by antibiotic multidrug-resistant bacteria seriously threaten human health. To
prevent and cure the infections caused by multidrug-resistant bacteria, new antimicrobial agents are required.
Antimicrobial peptides are ideal therapy candidates for antibiotic-resistant pathogens. However, due to high production
costs, novel methods of large-scale production are urgently needed.
Results: The novel plectasin-derived antimicrobial peptide-MP1102 gene was constitutively expressed under the
control of the GAP promoter. The optimum carbon source and concentration were determined, and 4% glucose
(w/v) was initially selected as the best carbon source. Six media were assayed for the improved yield of recombinant
MP1102 (rMP1102). The total protein and rMP1102 yield was 100.06 mg/l and 42.83 mg/l, which was accomplished via
the use of medium number 1. The peptone and yeast extract from Hongrun Baoshun (HRBS, crude industrial grade,
Beijing, China) more effectively improved the total protein and the yield of rMP1102 to 280.41 mg/l and 120.57 mg/l
compared to 190.26 mg/l and 78.01 mg/l that resulted from Oxoid (used in the research). Furthermore, we
observed that the total protein, antimicrobial activity and rMP1102 yield from the fermentation supernatant increased
from 807.42 mg/l, 384,000 AU/ml, and 367.59 mg/l, respectively, in pH5.0 to 1213.64 mg/l, 153,600 AU/ml and
538.17 mg/ml, respectively in pH 6.5 in a 5-l fermenter. Accordingly, the productivity increased from 104464 AU/mg
rMP1102 in pH 5.0 to a maximum of 285412 AU/mg rMP1102 in pH 6.5. Finally, the recombinant MP1102 was purified
with a cation-exchange column with a yield of 376.89 mg/l, 96.8% purity, and a molecular weight of 4382.9 Da, which
was consistent with its theoretical value of 4383 Da.
Conclusions: It’s the highest level of antimicrobial peptides expressed in Pichia pastoris using GAP promoter so far.
These results provide an economical method for the high-level production of rMP1102 under the control of the GAP
promoter.
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Antimicrobial peptides (AMPs) are widely distributed
host defense molecules that are produced by certain
single-cell organisms, including prokaryotic and eukaryotic
organisms, as well as all multicellular plants and animals
[1]. Plectasin is a recently reported novel defensin-like
AMP from Pseudoplectania nigrella that has potent anti-
microbial activity against gram-positive pathogens, such as
Staphylococcus aureus, Streptococcus pneumoniae and S.
suis, including some antibiotic-resistant strains [2,3].
Similar to vancomycin, plectasin binds to the pyrophos-
phate moiety of lipid II and subsequently prevents the
formation of the bacterial cell wall, which inhibits
colonization of the pathogens [4]. NZ2114 is a novel
variant of plectasin that has significantly more potent
activities than its parental peptide plectasin [5,6]. NZ2114
is active against various strains of S. pneumoniae and
S. aureus in vitro and in vivo [5,7,8]. To further improve
its antibacterial activity and physical and chemical prop-
erties, a new sequence named MP1102 was designed
which had three mutational sites (N9E, L13V, R14K)
compared to NZ2114 in our laboratory. The minimal
inhibitory concentrations (MICs) of MP1102 for S. aureus
ATCC25923, ATCC29213 and ATCC43300 were 0.021,
0.06 and 0.06 μM, respectively, and these values were
equal to or more potent than those of its parental peptide
NZ2114, which are 0.028, 0.11 and 0.9 μM, respectively.
The methylotrophic yeast Pichia pastoris has been
successfully used as a host system for the expression
of heterologous proteins. The high-level expression of
heterologous protein by P. pastoris has typically been
achieved using a pAOX1 expression system. However,
this system is inconvenient during fermentation due to
tedious processing and can create environmental pol-
lution or fires during transportation. A constitutive
glyceraldehyde-3-phosphate dehydrogenase (GAP) pro-
moter was used as an alternative to the AOX promoter
(Waterham et al. [9]). GAP is essential in carbohydrate
metabolism; thus the target proteins of this promoter are
expressed during the growth of the host. Consequently,
cultivation is simplified because methanol is not needed
as a carbon source. It gave comparable expression levels
to the AOX1 promoter for some proteins, including
β-Lactamase [9], xylanase [10], and human granulocyte-
macrophage colony stimulating factor [11,12]. However,
the operations manual of GAP promoter in P. pastoris
indicated that toxic target proteins to the Pichia cell
cannot be expressed with high yields (Invitrogen, Manual
part no: 25–0174). Consequently, only LL37 (intracellular
expression, no exact yield), human α-defensin 5 (1 mg/l)
and cecropin D (485 mg/l) have been expressed with
the GAP promoter [13-15]. NZ2114 is a peptide that
has low toxicity to host cells and is produced at high
levels in P. pastoris expression systems [16]. MP1102 isan NZ2114-derived antimicrobial peptide without tox-
icity to P. pastoris that has been expressed behind the
AOX promoter to produce a yield of 695 mg/l (accepted
by Appl Microbiol Biotechnol, DOI 10.1007/s00253-
015-6394-7), which is lower than the production of
NZ2114 (2,390 mg/l). The GAP promoter was used as
an alternative to the AOX promoter in this study.
In the P. pastoris expression system using the GAP
promoter, the carbon source is the key element for
heterologous protein expression [17]. Additionally, the
medium is another key factor for the high-level expres-
sion of heterologous protein. Various types of basal salts
media (BSM) are widely used at the fermenter level in
P. pastoris expression systems. However, the definite and
limited nutrients of BSM are not suitable for the large-
scale production of all proteins. An effective and cheap
industrial medium is urgently needed for the industrial
production of MP1102.
In the present study, the recombinant plasmid
pGAPMP1102 was constructed and transformed into
P. pastoris X-33. The optimum carbon source and its
concentration were determined. Additionally, the effects
of Oxoid and HRBS yeast extracts and peptones (crude
industrial grades) were compared, and the effects of five
different pH values were evaluated in a 5-l fermenter
using fed-batch fermentation. The recombinant MP1102
(rMP1102) was purified with a cation-exchange column and
confirmed by matrixassisted laser desorption/ionization-
time of flight mass spectrometry (MALDI-TOF MS).
Results
Vector construction and screening of positive transformant
As shown in Figure 1, the pGAPMP1102 plasmid con-
tained an inserted target MP1102 fragment of 120 bp.
All positive transformants were verified by sequencing.
The correct pGAPMP1102 recombinant plasmid was
linearized with AvrII and transformed into P. pastoris
X-33 by electroporation. The positive transformants
were screened by PCR using GAP gene-specific and
MP1102 gene-specific primers, and an empty pPICZαA
vector transformant was used as the negative control
(data not shown).
Confirmation of the anti-S. aureus activity of the
transformant and carbon source screening
Thirty positive transformants were used for fermentation
in shake flasks. All transformants exhibited some level of
antimicrobial activity (Figure 2A). A predominant band
between 3.3 and 5.8 kDa was observed in lanes 1–7, the
total protein and rMP1102 yield of up to 43.6 mg/l
and 18.31 mg/l were observed after 72 h of cultivation
(Figure 2B).
Unlike the AOX1 promoter, which is inactive on
glucose and glycerol and requires methanol to initiate
Figure 1 Construction of the recombinant expression vector pGAPMP1102. α-factor: native S. cerevisiae α-mating factor secretion signal,
which can be self-cleaved by the endogenous Kex2 protease to leave a native sequence of target peptide; pAOX: methanol-inducible alcohol
oxidase one promoter from P. pastoris; pGAP: glyceraldehyde-3-phosphate dehydrogenase promoter from P. pastoris; PTEF1: transcription elongation
factor one gene promoter; PEM7: synthetic prokaryotic promoter; Zeocin: Zeocin resistance gene; pUC ori: replication and maintenance of the plasmid
in E. coli; CYC1 TT: transcription termination region.
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expresses target proteins on different carbon sources
[18]. The yield of rMP1102 increased with increasing
carbon source concentrations until 40 g/l. The max-
imum total protein level, rMP1102 yield and antimicro-
bial activity were 67.8 mg/l, 27.8 mg/l and 6400 AU/ml,
respectively, after 96 h of cultivation at an initial glucose
concentration of 40 g/l (Figure 3A, B). Additionally,
rMP1102 was not secreted into the medium at high
levels when low concentrations (10 and 20 g/l) of any of
the three carbon sources were used. However, the yields
of rMP1102 decreased to 26.16 and 18.71 mg/l in
glucose and maltose, respectively at concentrations of
50 g/l (P < 0.05), which suggested that excessive high
carbon source concentrations did not benefit the pro-
duction of rMP1102.
Medium selection for the high-level production of rMP1102
To identify the best medium for the high-level produc-
tion of rMP1102, six different media were examined. As
shown in Figure 3C, the highest total protein and
rMP1102 yield of 100.06 mg/l and 42.83 mg/l were
observed with Med-1 following 120 h of cultivation.
To further improve this yield and identify a suitable
medium for rMP1102 production, yeast extracts and
peptones from Oxoid and HRBS (crude industrial grades)
were added. The higher total protein, rMP1102 yield and
antimicrobial activity of 280.41 mg/l, 120.57 mg/l and
12800 AU/ml were observed following the addition of
industrial yeast extract and peptone to Med-1 (Figure 4A,
B); this yield was 2.80 times that observed with Med-1
alone. Additionally, the total protein, rMP1102 yield and
antimicrobial activity were 190.26 mg/l, 78.01 mg/l and
9600 AU/ml following the use of Med-1 with added Oxoidyeast extract and peptone (Figure 4A, B). Tricine-SDS–
PAGE revealed a target band of rMP1102 between 4.4
and 10.0 kDa that was more obvious following the use
of Med-1 with HRBS yeast extract and peptone than the
medium that contained Oxoid (Figure 4C, D), which
suggesting that industrial yeast extract and peptone
were more suitable for the production of rMP1102.
Development of fed-batch cultivation in bioreactors
The experiments involving the fermentation of rMP1102
in 5-l fermenters focused on pH because pH is the key
factor that influences the yields of target proteins [19].
The total protein level, rMP1102 yield and antimicrobial
activity of the fermentation supernatant increased from
807.42 mg/l, 367.59 mg/l and 38,400 AU/ml, respect-
ively, at pH 5.0 to the maximum values of 1213.64 mg/l,
538.17 mg/l and 153,600 AU/ml, respectively, at pH6.5
(Table 1). However, the corresponding values decreased
to 1127.38 mg/l, 503.92 mg/l and 102,400 AU/ml at
pH 7.0, which was not the perfect condition for the
growth of the host and target peptide production in
P. pastoris. This pattern of productivity paralleled the
absolute antimicrobial activity values. The lowest prod-
uctivity was 104464 AU/mg rMP1102, which was
observed at the pH of 5.0, and the maximum max value
occurred in pH 6.5 and was 285412 AU/mg rMP1102.
However, productivity did not increase when the pH
was raised to 7.0 (Table 1). Moreover, a wider target
band resulted from pH 6.5 compared to the other pH
values (Figure 5A, C, E, G, I). Additionally, the cell wet
weights and total protein levels increased with the
process of cultivation in all pH values (Figure 5B, D, F,
H, J). The total protein level increased to the maximums
at 84 and 96 h in the pHs of 5.0, 5.5, and 6.0. However,
M 1 2 3 4 5 6 7
A
B
Figure 2 Screening and analyses of the positive transformants. A: Antimicrobial activity screening of the positive transformants of Pichia
pastoris GAPMP1102. 1–30: the fermentation supernatants of the different transformants of Pichia pastoris GAPMP1102; 31: the fermentation
supernatant of Pichia pastoris X-33; 32: 0.5 μg ampicillin. B: Tricine-SDS-PAGE analyses of the different transformants with positive antimicrobial
activities. M: A total of 5 μl of protein molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa); Lanes 1–7: Totals of 10 μl
fermentation supernatants of different transformants of Pichia pastoris GAPMP1102. The arrow indicates rMP1102.
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occurred at 120 h at the pHs of 6.5 and 7.0, which
suggested that these conditions were beneficial for the
continuous accumulation of rMP1102, whereas the
target peptides accumulated faster in the low 5.0, 5.5,
and 6.0 pH conditions (Figure 5B, D, F, H, J). rMP1102
was also expressed in P. pastoris via the inducible
method at the 5-l fermenter level. The maximum total
protein level was 695 mg/l at 120 h (accepted by Appl
Microbiol Biotechnol, DOI 10.1007/s00253-015-6394-7),
which was more than 70% reduced compared to the
constitutive expression at pH 6.5. Furthermore, another
non-target band appeared above rMP1102 between 3.3
and 5.8 kDa. This band might have represented incom-
plete cleavage by Kex2 due to the large amount of target
peptides that were induced by methanol in a short time
[20]. In contrast, there only the target rMP1102 wasexpressed in each of the assays that used the GAP
promoter (Figure 5A, C, E, G, I). Very few or no other
bands appeared around rMP1102, which was conveni-
ent for the process of purification.
Purification and identification of rMP1102
rMP1102 was purified from the culture supernatant
using a two-step purification protocol in a 5-l fermenter
using Med-1 supplemented with industrial yeast extract
and peptone at pH 6.5. As shown in Table 2, after the
two-step purification, a total of 1.273 × 108 AU and
376.89 mg of protein was obtained from 1000 ml of
culture supernatant (Table 2). The final recovery yield,
based on total activity, was 82.9%. A single band of
rMP1102 from the purified sample was observed and
exhibited a purity of 96.8% (Figure 6A). The results of































































































Figure 3 Carbon sources and medium selection for the high-level production of rMP1102 at the shake flask level. A, B: Effects of
different carbon sources on the total protein levels and antimicrobial activities of the fermentation supernatants of Pichia pastoris GAPMP1102;
C: Total protein levels of the fermentation supernatants of Pichia pastoris GAPMP1102 in the different media; D Tricine-SDS-PAGE analysis of
fermentation supernatant of Pichia pastoris GAPMP1102 in Med-1. Lane M: a total of 5 μl of protein molecular weight marker (from top to bottom: 40,
25, 15, 10, 4.6 and 1.7 kDa). Lanes 1–6: 10 μl of rMP1102 fermentation supernatants taken at 0, 24, 48, 72, 96, and 120 h of induction, respectively. The
arrow indicates rMP1102. Each data point is the average of three replicates, and the error bars represent the standard deviation. Different lowercase
letters (a, ab, b, c) above the bar indicate significant differences between groups (P < 0.05).
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which is consistent with its theoretical value of 4383 Da
(Figure 6B).
Discussion
The main hosts used for AMP production are bacteria
and yeasts, which are used to produce 97.4% of the het-
erologously expressed AMPs [21]. Due to the mecha-
nisms of membrane disruption and cell wall compound
blocking, which induce death [4,22], very low yields
of target peptides are obtained by directly expressing
AMPs in prokaryotic expression systems. Therefore,
fusion partners, such as thioredoxin (Trx), glutathione-
S-transferase (GST) and small ubiquitin-related modi-
fier (SUMO), have been introduced to avoid host
toxicity [23-25]. However, it is quite difficult to recover
large fusion proteins at reasonable ratios, so this process
is uneconomical and laborious. P. pastoris is a high-
yield host for the antimicrobial peptide production and
has some advantages over prokaryotic expression systems
[26]. Moreover, compared to mammalian cell cultures,
P. pastoris is more cost-effective and grows faster. Con-
sequently, the majority of heterologous AMPs produced
in yeast are expressed in P. pastoris [22].
The most commonly used vectors harbor the AOX
promoter in P. pastoris, which is induced by methanol.Many AMPs have been expressed using this promoter,
including hPAB-β [27], ABP-CM4 [28] and Ch-penaeidin
[29]. Additionally, fungal defensin-plectasin and its
derived peptides NZ2114, LHP7, and AgPlectasin have
also been successfully expressed using this system in
our laboratory with high production rates of 2390 mg/l,
906 mg/l, and 1285 mg/l, respectively [3,16,30,31]. How-
ever, methanol is a substance that is prone to cause fires
during transportation and storage. The GAP promoter is
an attractive alternative to the AOX promoter and might
reduce costs and risks during the processes of fermen-
tation and transportation. It has been shown that the
various proteins, such as bacterial β-lactamase [9], D-amino
acid oxidase and [32], human angiostatin [33], and func-
tional mammalian membrane transport protein production
[34], are more effectively expressed in constitutive systems
than in the methanol-inducible system. In this work, all
of the positive transformants exhibited some level of
antimicrobial activity different levels (Figure 2A, B),
However, the maximum total protein and rMP1102
yield were 43.6 mg/l and 18.31 mg/l after 72 h of culti-
vation (Figure 2C), which leaves much room for
improvements via the optimization of fermentation.
Glyceraldehyde-3-phosphate dehydrogenase is the
crucial enzyme in sugar metabolism. Consequently, the



































































Figure 4 Effects of peptone and yeast extracts from Oxoid and HRBS (crude industry level) on the production of rMP1102. A, B: Effects
of the peptone and yeast extracts on the total protein levels and antimicrobial activities of the fermentation supernatants of Pichia pastoris
GAPMP1102. C: Tricine-SDS-PAGE analyses of the fermentation supernatants from Pichia pastoris GAPMP1102 in Med-1 supplemented with peptone
and yeast extract from Oxoid. Lane M: a total of 5 μl of protein molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa).
Lanes 1–6: 10 μl of the rMP1102 fermentation supernatants taken at 0, 24, 48, 72, 96, and 120 h of induction, respectively. D: Tricine-SDS-PAGE
analysis of the fermentation supernatants from the Pichia pastoris GAPMP1102 in Med-1 supplemented with peptone and yeast extract from
HRBS (crude industry level). Lane M: a total of 5 μl of protein molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa). Lane
1–6: 10 μl of rMP1102 fermentation supernatants taken at 0, 24, 48, 72, 96, and 120 h of induction, respectively. The arrow indicates rMP1102.
Each data point is the average of three replicates, and the error bars represent the standard deviation. Different lowercase letters (a, b, c) above
the bar indicate significant differences between groups (P < 0.05).
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transport activities of rPEPT2 growing on glucose are
approximately 2 and 8 times greater than those on
glycerol and methanol, respectively [34]. Additionally,
glucose at 40 g/l is the best choice for both cell growthTable 1 Productivity related parameters of Pichia pastoris GA
conditions
pH 5.0 pH 5.5
Total protein (mg/l) 807.42 ± 26.35 913.28 ± 22.94
rMP1102 (mg/l) 367.59 ± 13.51 423.62 ± 18.27
Activity (AU/ml × 10000) 3.84 ± 0.31 5.12 ± 0.28
Max cell wet weight (g/l) 341.2 ± 19.41 378.5 ± 17.13
Specific cell growth rate (μ) 0.188 0.189
Productivity (AU/mg rMP1102) 104464 120863and lipase production [35]. However, glycerol is a better
carbon source than glucose or methanol for the produc-
tion of human angiostatin [33]. It was also found that
the methanol could also initiate the expression the re-
porter of β-lactamase, its activity was 36.36% comparedPMP1102 for fed-batch fermentation under different pH
pH 6.0 pH 6.5 pH 7.0
1076.99 ± 35.86 1213.64 ± 42.68 1127.38 ± 37.62
486.35 ± 17.96 538.17 ± 21.32 503.92 ± 19.85
10.24 ± 0.36 15.36 ± 0.43 10.24 ± 0.37
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Figure 5 (See legend on next page.)
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Figure 5 Effects of different pHs on the yield of rMP1102 via fed-batch fermentation. A, C, E, G, I: Tricine-SDS-PAGE analyses of the
fermentation supernatants of P. pastoris GAPMP1102 in pHs of 5.0, 5.5, 6.0, 6.5 and 7.0, respectively. Lane M: a total of 5 μl of protein
molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa). Lanes 1–7: Supernatants (10 μl each) harvested at 0, 24, 48, 72,
96, 108 and 120 h of cultivation, respectively. The arrow indicates rMP1102. B, D, F, H, J: Cell wet weights and total protein levels of the fermentation
supernatants of P. pastoris GAPMP1102 in pHs of 5.0, 5.5, 6.0, 6.5 and 7.0, respectively. K: Antimicrobial activity of the fermentation supernatants of P. pastoris
GAPMP1102 in pHs of 5.0, 5.5, 6.0, 6.5 and 7.0, respectively. L: Tricine-SDS-PAGE analysis of the fermentation supernatant of P. pastoris AOXMP1102 in
pH 5.0. Lane M: a total of 5 μl of protein molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa). Lanes 1–6: supernatants (10 μl each)
harvested at 0, 24, 48, 72, 96, and 120 h of cultivation, respectively. The arrow indicates rMP1102. Each data point is the average of three replicates, and the
error bars represent the standard deviation. Different lowercase letters (a, b, c, d) above the bar indicate significant differences between groups (P < 0.05).
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carbon sources were tested at different concentrations
in our work. The findings revealed that the maximum
productions in terms of total protein, rMP1102 yield
and antimicrobial activity were 67.8 mg/l, 27.8 mg/l and
6400 AU/ml following 96 h of cultivation at an initial
glucose concentration of 40 g/l (Figure 3A, B).
Basal salt medium (BSM) and FM22 are the defined
media commonly used in the large-scale production of
heterologous proteins [36]. The present work revealed
that the maximum total protein level and rMP1102 yield
in the defined medium were 100.06 mg/l and 42.83 mg/l,
which was achieved using Med-1 (Figure 3C) at the shake
flask level. Additionally, rich media might be more
favorable than defined media for the production of
some proteins. Yeast extract, peptone, and casamino
acids are the complex media that are typically added to
defined medium [36]. These media can enhance the
yield of target protein and protect host cells from pro-
teolytic degradation. It has been shown that recombin-
ant human consensus IFN-α (IFN-Con1) mutant can
be highly expressed with a maximum yield of 1.23 g/l
via the addition of yeast extract and peptone [37].
Similarly, the highest yield of total protein, rMP1102
and antimicrobial activity of 280.41 mg/l, 120.57 and
12800 AU/ml was observed following the use of Med-1
supplemented with crude industrial yeast extract and
peptone (Figure 4A, B). However, the yield of total
protein, rMP1102 and antimicrobial activity reduced to
190.26 mg/l, 78.01 mg/l and 9600 AU/ml when Med-1
supplemented with Oxoid yeast extract and peptone
was used (Figure 4A, B), which suggests that industrial
media are more suitable for the high-level production
of this target peptide. This difference might be due to
the extensive machining processes that might keep the
certain micronutrients in the industrial grade mediumTable 2 Purification and yield of rMP1102
Volume (ml) Protein concentration (mg/l) Specifi
Culture supernatant 1000 1213.64 ± 42.68 15.36 ±
Sephadex G-25 2600 357.31 ± 17.14 5.37 ± 0
SP FF
Sepharose 820 376.89 ± 15.83 15.52 ±that improved target peptide yield. However, the exact
mechanism will be studied in our future work. More-
over, the costs of industrial yeast extract and peptone
were $ 9.68 and 11.29 per kilogram (Table 3), which
were 3.17 and 7.57 times lower than the costs of the
Oxoid components, respectively (Table 3); thus, the
industrial yeast extract and peptone are likely more
suitable for large-scale production.
Because P. pastoris grows in a wide range of pHs, the
optimization of fermentation is typically adapted within
these limits to provide the best conditions for individual
proteins [19]. The expression level of sEDIII-2 is highest
at a pH of 5.8, and this level is 20–25% higher than
those achieved at other pH values [38]. Moreover, it has
been found that an induction pH of 6.8 results in a
merozoite surface protein 3 (MSP3) yield of at 434 mg/L,
whereas this is no product at pH 5.0 despite though
cell growth being identical across all pH levels [39].
Consequently, pH values of 5.0 to 7.0 were selected
for rMP1102 production at the 5-l fermenter level. The
greatest amount of total protein, rMP1102 yield and
antimicrobial activity were 1213.64 mg/l, 538.17 mg/l
and 153,600 AU/ml in pH 6.5, with the highest product-
ivity and specific cell growth rate of 285412 AU/mg
rMP1102 and 0.224, respectively (Table 1), which
corroborates the notion that, under the GAP promoter,
the target peptide production was accompanied by the
growth of host cells [9]. Furthermore, this was the high-
est yield of antimicrobial peptide achieved using the
GAP promoter and thus provides a practical system for
the large-scale production of antimicrobial peptides
with structures similar to that of MP1102.
Conclusions
For the first time, the novel NZ2114-derived peptide






Figure 6 Purification and identification of rMP1102. A: MALDI-TOF MS analysis of the purified rMP1102. B: Tricine-SDS-PAGE analysis of the
purified rMP1102. Lane M: A total of 5 μl of protein molecular weight marker (from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa). Lanes 1–2:
purified rMP1102 (0.1 μg). The arrow indicates rMP1102.
Mao et al. BMC Microbiology  (2015) 15:57 Page 9 of 12promoter. Four percent initial glucose and Med-1 were
identified as the best carbon source and medium, respect-
ively, among three carbon sources and six media. Moreover,
the replacement of Oxoid peptone and yeast extract (used
in the research) with HRBS (crude industrial grade) was
beneficial in terms of a higher yield of rMP1102. Addition-
ally, the total protein level, rMP1102 yield, and antimicro-
bial activity increased from 807.42 mg/l, 367.59 mg/l, and
38,400 AU/ml, respectively, in pH 5.0 to the maximum
values of 1213.64 mg/l, 538.17 mg/l and 153,600 AU/ml, re-
spectively, at in pH 6.5. Together, the above results provide
an economical strategy that is suitable the production of
rMP1102 at the industrial level under the control of the
GAP promoter in P. pastoris for the first time.
Methods
Strains, vectors, and reagents
Escherichia coli DH5α (Invitrogen, Beijing, China) was
used as the host for plasmid maintenance and amplification.Table 3 Costs of peptone and yeast extracts
Medium Price ($)
Yeast extract (HRBa) 9.68
Yeast extract (Oxoid) 40.32
Peptone (HRB) 11.29
Peptone (Oxoid) 96.77
aThe media from Hongrunbaoshun Co., Lod.The pPICMP1102 plasmid was constructed and saved
in our laboratory. The GAP gene was synthesized by
Sangon Biotech (Shanghai, China). P. pastoris X-33
(Invitrogen, Beijing, China) was used for the expression.
S. aureus ATCC 25923 was used in the antimicrobial
activity assays. Restriction enzymes were purchased
from New England Biolabs (NEB, Beijing, China). The
kits for plasmid extraction and DNA purification were
purchased from Tiangen (Beijing, China). All other
chemical reagents were of analytical grade.
Construction of pGAPMP1102 and screening of the
transformants
The pPICMP1102 recombinant plasmid was constructed in
previous work [40]. The AOX promoter of pPICMP1102
was replaced with the GAP promoter in this study, its
detail including the restriction sites (Bgl II and Xho I)
was shown in Figure 1. The target peptide was inserted
in the downstream of the α-factor, which is most widely
and successfully used secretion signal and can be self-
cleaved by the Kex2 protease in P. pastoris, resulting in
the native sequence of target protein. The recombinant
plasmid was named pGAPMP1102 (GenBank accession
number: KP636420) and transformed into E. coli DH5α.
The positive transformants were screened by colony
PCR and DNA sequencing. The correct positive plasmid
was linearized with AvrII and transformed into P. pastoris
X-33 by electroporation at 1,200 V charging voltage. The
Mao et al. BMC Microbiology  (2015) 15:57 Page 10 of 12positive transformants were selected on YPDS plates
(20 g/l peptone, 10 g/l yeast extract, 20 g/l glucose,
182.2 g/l sorbitol, and 20 g/l agar) containing 100 μg/ml
Zeocin. The transformants were further confirmed by
colony-PCR.
Expression of rMP1102 and optimization of cultivation in
shaking flasks
The positive transformants were cultured overnight at
29°C and 250 rpm in 50-ml shaking flasks containing
10 ml YPD medium (20 g/l peptone, 10 g/l yeast extract,
20 g/l glucose). A 500-μl overnight culture was inocu-
lated into a 250-ml shaking flask containing 50 ml YPD
medium. Glucose (50%) was repeatedly added every 24 h
to a final concentration of 0.5-1.0% (v/v) during the 72 h
expression period, and the cell supernatants was collected
every 24 h. The collected supernatants were centrifuged at
12,000 rpm for 10 min and stored at −20°C.
The colony with the highest expression level was se-
lected and grown in 10 ml YPD medium overnight. This
cell culture was further inoculated to an optical density
(OD600) of 0.1-0.3 to initiate the cell growth and protein
expression in the modified YP media (1% (w/v) yeast
extract, 2% (w/v) peptone) supplemented with different
carbon sources (i.e., glucose, glycerol, or methanol) at
different concentration of 1, 2, 3, 4, and 5% (w/v). The
culture supernatants were collected, and total protein
levels were measured with a Bradford protein assay kit
(Tiangen Biotech, Beijing, China). The yield of rMP1102
was calculated with Quantity One software, Version
4.6.2 (Bio-Rad, USA). The antimicrobial activity was
assayed by the method described in the “Antimicrobial
activity assays” section.Table 4 Composition of media used in rMP1102 production a










Citric acid 1.92 —
Glucose 40 40
Peptone — —
Yeast extract — —
PTM1 0.48% 0.48%
Reference [42] [35]Based on the results of the carbon source screening,
six different media (Table 4) were used to select the
most suitable medium for large-scale production. In
detail, a single colony of the recombinant strain was
grown in 10 ml of YPD medium overnight and inocu-
lated into 50 ml of YPD medium. The cell culture was
further inoculated to an optical density (OD600) of
0.1-0.3 to initiate the cell growth and protein expression
in 200 ml volumes of different media (Table 4). Glucose
(50%) was repeatedly added every 24 h to a final con-
centration of 4.0% (v/v) during the 96 h expression
period, and the cell supernatants were collected every
24 h. The total protein levels, rMP1102 yield and anti-
microbial activities were tested. Tricine-SDS-PAGE was
used to evaluate the expression levels of the target
peptides. In this system, tricine is used instead of
glycine in the cathode buffer due to that its stronger
negative charge than glycine allows peptide to migrate
faster. In addition, more ion movement and less protein
movement from high ionic strength improves small
proteins to be separated [41].
To further improve the rMP1102 yield, 2% peptone and
1% yeast extract from Oxoid (which are commonly used
for research) and from Hongrun Baoshun (HRBS, these
were crude and industrial grade) were added to Med-1,
which was the medium that resulted in the maximum
production of the target peptides. The methods for the
cultivation, and total protein level and Tricine-SDS-PAGE
assays were those described in the preceding paragraph.
Fed-batch fermentation at different pHs
The fermentation studies were conducted in 5-l bioreac-
tors (BIOSTAT®B plus, Sartorius Stedim Biotech). Assays
Med-3 (BSM) Med-4 YPD BMGY
— 6 — —
26.7 ml — — —
— — — —
— 50 — —
0.93 0.4 — —
— — — —
18.2 20 — —
14.9 15 — —
4.13 1.5 — —
— — — —
40 40 40 40
— — 20 20
— — 10 10
0.48% 0.48% 0.48% 0.48%
[43] [16] — —
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An overnight culture was inoculated into 200 ml of fresh
YPD medium and cultivated at 29°C (250 rpm) to an
OD600 of 4–6. Next, 10% (v/v) inoculum was inoculated
into a 5-L fermenter containing 2.0 L modified Med-1
medium (42.9 g/L KH2PO4, 14.3 g/l K2SO4, 11.7 g/l
MgSO4 7H2O, 5 g/l (NH) 2SO4, 1.92 g/l citric acid
anhydrous, 0.6 g/l CaSO4, 20.0 g/L yeast extract, 40.0 g/L
peptone, 40.0 g/L glucose). The pH value was set to 6.0 at
the glucose batch phase and changed to 5.0, 5.5, 6.0, 6.5,
or 7.0 in the glucose fed-batch phase using NH4OH and
H3PO4. The glucose feeding rate was 6 mL/L/h during the
fed-batch culture phase. The dissolved oxygen (DO) level
was maintained between 25 and 40% by adjusting the
agitation, aeration, and rates. Foaming was controlled
via the addition of antifoam. Cultivation broth samples
were taken every 12 h for cell wet weight, extracellular
protein level and antimicrobial activity analyses after
centrifugation at 12,000 rpm for 10 min. The total pro-
tein levels, rMP1102 yield and antimicrobial activities
were tested.
Purification and identification of rMP1102
The fermentation supernatant was dialyzed using a
Sephadex G-25 column and lyophilized. The dried powder
was dissolved in 20 mM of sodium phosphate buffer at a
pH of 6.7 and loaded onto a HiTrap SP FF cation ex-
change chromatography (cIEX) column (length, 25 mm;
internal diameter, 7 mm; GE Healthcare). First, 20-mM
sodium phosphate buffer and 140-mM NaCl at a pH of
6.7 were used for elution, the concentration of NaCl
was then increased to 600 mM, and the eluent of the
corresponding elution peak was collected. Protein elu-
tion was monitored by measuring the UV absorbance at
215 and 280 nm.
The purified rMP1102 was analyzed by tricine-SDS-PAGE
and confirmed by MALDI-TOF MS at the Laboratory of
Proteomics, Institute of Biophysics, the Chinese Academy of
Sciences according to previously reported methods [24].
The purity of the target peptide was calculated with
Quantity One software, version 4.6.2 (Bio-Rad, USA).
Antimicrobial activity assays
The tested strain of S. aureus ATCC 25923 was grown
at 37°C to an OD600 of 0.4 in Mueller–Hinton (MH)
medium (5 g/l beef infusion solids, 17.5 g/l casein
hydrolysate, 1.5 g/l starch, and 3% serum, pH7.4). The
cell suspension was inoculated into preheated MHA
(5 g/l beef infusion solids, 17.5 g/l casein hydrolysate,
1.5 g/l starch, 20 g/l agar, 3% serum, pH 7.4). The
medium was rapidly mixed and poured into a petri dish.
Sterile oxford cups were placed on the surface of solidi-
fied the medium, and each cup was filled with 50-μl
samples and incubated for 16–18 h at 37°C [44].A titer assay was used to quantify the antimicrobial
activity, which is expressed as arbitrary units (AU/ml).
One arbitrary unit (AU) was defined as the reciprocal of
the highest dilution that exhibited a clear zone of inhib-
ition with the indicator strain. When a clear inhibition
zone was followed by a turbid zone, the critical dilution
was taken as the average of the final two dilutions [42].
Statistical analyses
All statistical analyses were performed using SPSS version
22.0. One-way analysis of variance (ANOVA) was used
to determine the significance of the differences between
groups. Differences were considered significant at P < 0.05.
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